Board of Directors

Arway
Pamela M. Arway
Chair of DaVita's Board of Directors and Former President of the Japan, Asia-Pacific, Australia region for American Express International, Inc.
Pamela M. Arway has been one of our directors since May 2009. From 2005 to 2008, Ms. Arway served as the president of the Japan, Asia-Pacific, Australia region for American Express International, Inc., a global payment services and travel company. Ms. Arway joined the American Express Company in 1987, and subsequently served in various capacities, including as chief executive officer of American Express Australia Limited from 2004 to 2005 and as executive vice president of Corporate Travel, North America from 2000 to 2004. Prior to her retirement in October 2008, she also served as advisor to the American Express Company’s chairman and chief executive officer. Since May 2010, Ms. Arway has been a member of the board of The Hershey Company, a chocolate and confectionery company. She currently serves as a member of the Compensation and Finance and Risk Management Committees of The Hershey Company’s board. Since March 2014, Ms. Arway has been a member of the board of Iron Mountain Incorporated, an enterprise information management services company and currently serves as chair of its Compensation Committee and as a member of the Nominating and Governance Committee.
Charles G. Berg
Charles G. Berg
Former Executive Chair, DaVita Medical Group
Charles G. Berg has been one of our directors since March 2007, and from November 2016 until December 2017, also served as executive chair of our former integrated healthcare business, DaVita Medical Group (“DMG”). On March 25, 2019, Mr. Berg joined the board of directors of Turn-Key Health, an Enclara Healthcare Company, serving health plans, provider organizations and their members who experience a serious or advanced illness. From 2008 to 2013, Mr. Berg served as executive chairman of WellCare Health Plans, Inc. (“WellCare”), a provider of managed care services for government-sponsored health care programs. Mr. Berg served as non-executive chairman of the board of directors of WellCare from January 2011 until his retirement in May 2013. From January 2007 to April 2009, Mr. Berg was a senior advisor to Welsh, Carson, Anderson & Stowe, a private equity firm. From April 1998 to July 2004, Mr. Berg held various executive positions, including executive vice president-medical delivery, president and chief operating officer with Oxford Health Plans, Inc. (“Oxford”), a health benefit plan provider. He was the chief executive officer when Oxford was acquired by UnitedHealth Group. He then became an executive of UnitedHealth Group and was primarily responsible for integrating the Oxford business. Mr. Berg currently serves as a member of the Operating Council & Senior Advisory Board of Consonance Capital Partners, a private equity firm, and the board of directors of Justworks, Inc., a private human resources and payment company.
Barbara Desoer
Barbara J. Desoer
Former Chief Executive Officer, Citibank, N.A.

Barbara J. Desoer, has been one of our directors since October 2015. Ms. Desoer served as the chief executive officer and a member of the board of directors of Citibank, N.A., a wholly owned subsidiary of Citigroup Inc. and a diversified global financial services company, both positions she held from April 2014 through April 2019. On April 16, 2019, Ms. Desoer joined the board of directors of Citigroup Inc. Ms. Desoer previously served as the chief operating officer of Citibank, N.A. from October 2013 to April 2014.

Prior to Citibank, Ms. Desoer spent 35 years at Bank of America, a diversified global financial services company, most recently as president, Bank of America Home Loans, where she led the integration of Countrywide, the largest mortgage originator and servicer in the United States. In previous Bank of America roles, Ms. Desoer was a Global Technology & Operations executive, an international market-focused position leading teams in the United Kingdom, Asia and Latin America. She also served as president, Consumer Products. She serves on the board of visitors at the University of California at Berkeley. Ms. Desoer also has served on the board of directors of various non-profit and privately held corporations.

Pascal Desroches
Pascal Desroches
Executive Vice President and Chief Financial Officer, WarnerMedia Inc.
Pascal Desroches has been one of our directors since January 2017. Mr. Desroches is the executive vice president and chief financial officer of WarnerMedia Inc. (“WarnerMedia”). WarnerMedia is one of four distinct business units operating under AT&T Inc., a leading provider of telecommunications, media and technology services globally. Mr. Desroches is responsible for all of WarnerMedia’s financial operations, facilities and technology organizations. Prior to his current role, Mr. Desroches was the executive vice president and chief financial officer of Turner, a subsidiary of Time Warner Inc. (“Time Warner”), a global media and entertainment company, a position he had held since 2014. Mr. Desroches was also responsible for Turner’s global technology, security and facilities organizations. Prior to joining Turner, from December 2007 to December 2014, Mr. Desroches was the senior vice president and controller of Time Warner, a global leader in media and entertainment, where he was responsible for overseeing internal and external financial reporting, financial planning and analysis, procurement services, shared services program management, and worked on the management team responsible for mergers and acquisitions and other transactions. Prior to joining Time Warner, Mr. Desroches was a partner in KPMG LLP’s Department of Professional Practice Assurance & Advisory Services in New York from 2000 to 2001. Prior to being admitted into KPMG LLP’s partnership, Mr. Desroches was a professional accounting fellow with the Office of the Chief Accountant of the SEC.
Paul J. Diaz
Paul J. Diaz
Chief Executive Officer, Myriad Genetics, Inc.
Paul J. Diaz has been one of our directors since July 2007. Mr. Diaz currently serves as the chief executive officer (CEO) and member of the board of directors for Myriad Genetics. Previously, Mr. Diaz was a partner at Cressey & Company LP, a private equity firm focused exclusively on investing in and building health care businesses, and now serves as a partner emeritus and a member of its Distinguished Executive Council. Since 2014, Mr. Diaz has served as founding partner at Guidon Partners LP, a private investment partnership. He guided Kindred Healthcare, Inc. (“Kindred”), a provider of long-term health care services in the United States, as CEO from 2004 until 2015 and president from 2002 to 2012. Prior to joining Kindred, Mr. Diaz was the managing member of Falcon Capital Partners, LLC, a private investment and consulting firm. From 1996 to 1998, Mr. Diaz served in various executive capacities with Mariner Health Group, Inc., a health care facility operator, including as executive vice president and chief operating officer. Mr. Diaz also serves on the board of Performance Health, a private medical supply distribution company, the board of trustees of Johns Hopkins Medicine and the board of visitors of the Georgetown University Law Center.
Shawn Guertin
Shawn Guertin
Former Executive Vice President, Chief Financial Officer and Chief Enterprise Risk Officer, Aetna, Inc.

Shawn Guertin has been one of our directors since September 2020. Most recently, he spent eight years at Aetna, Inc., where he served as executive vice president, chief financial officer and chief enterprise risk officer during a period of significant growth driven by acquisitions and expansion into government programs, leading to Aetna’s eventual merger with CVS Health.

Shawn started his career as an actuary for The Travelers, where he held a number of different roles over 11 years, eventually becoming part of the leadership of its group health business that was acquired by UnitedHealthcare. After a time working for UnitedHealthcare, Shawn joined Coventry Health Care, where he spent 12 years, including serving as chief actuary and chief financial officer.

He will serve on DaVita’s audit committee; he also holds a position on the TriNet Board of Directors, serving as a member of the audit committee.

John  Nehra
John M. Nehra
Former General Partner, New Enterprise Associates
John M. Nehra has been one of our directors since November 2000. From 1989 until his retirement in August 2014, Mr. Nehra was affiliated with New Enterprise Associates (‘‘NEA’’), a venture capital firm, including, from 1993 until his retirement, as general partner of several of its affiliated venture capital limited partnerships. Mr. Nehra also served as managing general partner of Catalyst Ventures, a venture capital firm, from 1989 to 2013. Mr. Nehra served on the boards of a number of NEA’s portfolio companies until his retirement in August 2014 and remains a retired special partner of NEA.
Paula A. Price
Paula A. Price
Former Chief Financial Officer, Macy's Inc.

Paula A. Price has been one of our directors since September 2020. Most recently, she served as the chief financial officer of Macy's, Inc., and currently remains an advisor to the renowned retailer. Previously, she was a full-time senior lecturer for Harvard Business School in the Accounting and Management Department from 2014 to 2018. Prior to her time at Harvard, she served as the chief financial officer for Ahold USA, controller and chief accounting officer of CVS Caremark Corporation, and in senior leadership positions at JPMorgan Chase, Prudential Financial, Diageo and Kraft Foods. A certified public accountant, Paula began her career at Arthur Andersen & Co.

She currently serves on the boards of directors of Accenture plc and Western Digital Corporation, and will be joining the board of Bristol Myers Squibb. Paula previously served on the board of Dollar General Corporation.

Javier J. Rodriguez
Javier J. Rodriguez
Chief Executive Officer, DaVita Inc.

Javier Rodriguez is the chief executive officer of DaVita Inc. (NYSE: DVA), a FORTUNE 500 company providing health care services to kidney disease patients throughout the United States and internationally. DaVita strives to improve patients’ quality of life through clinical innovation and integrated, personalized care. DaVita’s global operations include 65,000 teammates serving 225,000 patients treating in-center, in their homes and in hospitals.

Mr. Rodriguez has spent more than 20 years driving DaVita’s transformation for how kidney care is delivered. He is passionate about creating an integrated, high-quality experience for all patients with kidney disease, while lowering costs for the health care system.

Mr. Rodriguez earned a master’s degree from Harvard Business School and completed an executive program at Stanford Graduate School of Business. He earned a bachelor’s degree in finance and marketing from Boston College. Mr. Rodriguez was named one of the 2015 Top 10 Leaders by Hispanic Executive magazine. He also serves on the board of directors for the Denver Metro Chamber of Commerce.

Phyllis Yale
Phyllis R. Yale
Advisory Partner, Bain & Company, Inc.
Phyllis R. Yale has been one of our directors since July 2016. Ms. Yale has been an Advisory Partner with Bain & Company, Inc. (“Bain”), a global management consulting firm, since July 2010. Ms. Yale was a partner with Bain from 1987 to July 2010, and was a leader in building Bain’s healthcare practice. In her role at Bain, Ms. Yale works with healthcare payors, providers, and medical device companies, and frequently advises the world’s leading private equity firms on their investments in the healthcare sector. She has served as a member of the board of directors of several public and private companies in the healthcare sector, and currently serves as Chair of the board of directors of Blue Cross Blue Shield of Massachusetts, a not-for-profit health plan headquartered in Boston. Ms. Yale previously served as Chair of the board of directors of Kindred HealthCare, Inc., a provider of long-term healthcare services in the United States, from January 2010 until July 2018, a director of National Surgical Hospitals, a privately held specialty hospital operator, and a director of ValueOptions, Inc., a health improvement company specializing in mental and emotional wellbeing and recovery, which merged with Beacon Health Strategies during 2014.

Contact Investor Relations

Jim Gustafson

Vice President, Investor Relations DaVita Inc.

601 Hawaii StreetEl Segundo, CA 90245

Phone:  (310) 536-2585